Table 2.
Univariate and multivariate analysis of serum miR-9 expression in OSCC overall survival.
| Parameters | Overall survival | |||
|---|---|---|---|---|
| Univariate OR (95%CI) | P | Multivariate OR (95%CI) | P | |
| Gender (Male vs. Female) | 1.256 (0.310–1.816) | 0.546 | ||
| Age (>60 vs. ≤60) | 1.413 (0.524–2.362) | 0.389 | ||
| Smoking status (Smoker vs. Non-smoker) | 1.108 (0.497–1.544) | 0.732 | ||
| Tumor site (Tongue vs. Non-tongue) | 0.867 (0.426–1.219) | 0.507 | ||
| T stage (T3–T4 vs. T1–T2) | 2.614 (1.318–4.354) | 0.038 | 2.961 (1.384–4.732) | 0.041 |
| Lymph node metastasis (Yes vs. No) | 4.390 (2.065–8.697) | 0.006 | 6.127 (2.546–10.873) | 0.008 |
| TNM stage (III–IV vs. I–II) | 3.017 (1.623–5.783) | 0.026 | 3.720 (1.856–6.028). | 0.024 |
| Grade (Poor vs. Well/moderate) | 1.935 (0.974–2.840) | 0.058 | ||
| Serum miR-9 expression (Low vs. High) | 3.621 (1.892–6.983) | 0.015 | 4.054 (1.980–7.862) | 0.019 |